Detailed View
ONC - BeOne Medicines Ltd.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
33,812,520,960
Adj EBIT (TTM)
1,028,904,000
Enterprise Value
30,108,755,960
Last Price
325.90
Earnings Yield
3.42%
Return on Capital
15.40%
Capital
6,680,428,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 1,513,438,000 | 249,902,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 1,498,170,000 | 185,035,000 |
| 2025-09-30 | 10-Q | 2025 | 1,412,284,000 | 163,114,000 |
| 2025-06-30 | 10-Q | 2025 | 1,315,300,000 | 87,885,000 |
| 2025-03-31 | 10-Q | 2025 | 1,117,279,000 | 11,102,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 1,127,824,000 | -79,425,000 |
| 2024-09-30 | 10-Q | 2024 | 1,001,599,000 | -120,265,000 |
| 2024-06-30 | 10-Q | 2024 | 929,166,000 | -107,161,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.